TAPPER: Is it time for the "Buried Lead." That's what we call stories we think aren't getting enough play. The Supreme Court is taking up a case that could impact anyone who's tried to save a little money on prescription drugs. At issue is a practice called pay to delay. It's when pharmaceutical companies pay the makers of generic drugs to hold off on putting those cheaper drugs on the market. The FTC says the practice is not only illegal, it hurts consumers, but drug companies argue that the system is a way to work around patent disputes. The high court is expected to rule on the issue this summer. We're just starting our second week and we want to hear from you. How's my driving? Let us know what you like, what we need to work on. E-mail us at the lead@cnn.com. Hash tag you're it. Earlier we asked you to come up with a title for Jim Carrey's next anti-gun song. May I present your best efforts, Lemony Snikts, a series of unfortunately box office bombs. That's not nice. And the eternal arrogance of the liberal mind, I guess, some conservative entrance. That does it for THE LEAD today. Be sure to join us every day this week at 4:00 p.m. Eastern. I'll turn you over to Kate Bolduan who is filling in today for Wolf Blitzer in THE SITUATION ROOM.
Rethinking the War on Drugs